Longitudinal Imaging of Liver Cancer Using MicroCT and Nanoparticle Contrast Agents in CRISPR/Cas9-Induced Liver Cancer Mouse Model
Introduction: Micro-computed tomography with nanoparticle contrast agents may be a suitable tool for monitoring the time course of the development and progression of tumors. Here, we suggest a practical and convenient experimental method for generating and longitudinally imaging murine liver cancer...
Prif Awduron: | Sang Bu An, Kwangmo Yang MD, PhD, Chang Won Kim MD, PhD, Si Ho Choi PhD, Eunji Kim, Sung Dae Kim, Jae Soo Koh |
---|---|
Fformat: | Erthygl |
Iaith: | English |
Cyhoeddwyd: |
SAGE Publishing
2021-05-01
|
Cyfres: | Technology in Cancer Research & Treatment |
Mynediad Ar-lein: | https://doi.org/10.1177/15330338211016466 |
Eitemau Tebyg
-
Evaluation of Radiation Sensitivity Differences in Mouse Liver Tumor Organoids Using CRISPR/Cas9-Mediated Gene Mutation
gan: Wan Jeon MD, et al.
Cyhoeddwyd: (2023-03-01) -
The Application of the CRISPR/Cas9 System in the Treatment of Hepatitis B Liver Cancer
gan: Wei Lv MSc, et al.
Cyhoeddwyd: (2021-09-01) -
Added Value of Liver MRI in Patients Eligible for Surgical Resection or Ablation of Colorectal Liver Metastases Based on CT: A Systematic Review and Meta-Analysis
gan: Burak Görgec, MD, et al.
Cyhoeddwyd: (2024-03-01) -
Cancer of the Liver and its Relationship with Diabetes mellitus
gan: Sunday Amos Onikanni PhD, et al.
Cyhoeddwyd: (2022-12-01) -
GPSM2 Serves as an Independent Prognostic Biomarker for Liver Cancer Survival
gan: Dingquan Yang PhD, et al.
Cyhoeddwyd: (2020-08-01)